Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan D Smith

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Plos Biology|October 11, 2012
Radar tracking and motion-sensitive cameras on flowers reveal the development of pollinator multi-destination routes over large spatial scalesMathieu Lihoreau, Nigel E Raine, Andrew M Reynolds, et al.
Ecology|September 11, 2009
Flight metabolic rate and Pgi genotype influence butterfly dispersal rate in the fieldKristjan Niitepõld, Alan D Smith, Juliet L Osborne, et al.
Proceedings. Biological Sciences|March 11, 2011
Convergent patterns of long-distance nocturnal migration in noctuid moths and passerine birdsThomas Alerstam, Jason W Chapman, Johan Bäckman, et al.
European Urology|January 19, 2021
Significantly Minimizing Drug Wastage and the Cost of Cabazitaxel Used to Treat Metastatic Castration-Resistant Prostate CancerDi Maria Jiang, Nazanin Fallah-Rad, Roy Lee, et al.
Expert Review of Anticancer Therapy|March 9, 2022
Lenvatinib dose, efficacy, and safety in the treatment of multiple malignanciesRobert J Motzer, Matthew H Taylor, Thomas R Jeffry Evans, et al.
European Urology|February 25, 2022
Assessing the Safety and Efficacy of Two Starting Doses of Lenvatinib Plus Everolimus in Patients with Renal Cell Carcinoma: A Randomized Phase 2 TrialSumanta K Pal, Javier Puente, Daniel Y C Heng, et al.
European Urology|March 12, 2016
Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate CancerPasquale Rescigno, David Lorente, Diletta Bianchini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2022
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in CombinationAna Arance, Luis de la Cruz-Merino, Teresa M Petrella, et al.
The New England Journal of Medicine|January 19, 2022
Lenvatinib plus Pembrolizumab for Advanced Endometrial CancerVicky Makker, Nicoletta Colombo, Antonio Casado Herráez, et al.
The Lancet. Oncology|June 18, 2021
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 studyChung-Han Lee, Amishi Yogesh Shah, Drew Rasco, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Plos Biology|October 11, 2012
Radar tracking and motion-sensitive cameras on flowers reveal the development of pollinator multi-destination routes over large spatial scalesMathieu Lihoreau, Nigel E Raine, Andrew M Reynolds, et al.
Ecology|September 11, 2009
Flight metabolic rate and Pgi genotype influence butterfly dispersal rate in the fieldKristjan Niitepõld, Alan D Smith, Juliet L Osborne, et al.
Proceedings. Biological Sciences|March 11, 2011
Convergent patterns of long-distance nocturnal migration in noctuid moths and passerine birdsThomas Alerstam, Jason W Chapman, Johan Bäckman, et al.
European Urology|January 19, 2021
Significantly Minimizing Drug Wastage and the Cost of Cabazitaxel Used to Treat Metastatic Castration-Resistant Prostate CancerDi Maria Jiang, Nazanin Fallah-Rad, Roy Lee, et al.
Expert Review of Anticancer Therapy|March 9, 2022
Lenvatinib dose, efficacy, and safety in the treatment of multiple malignanciesRobert J Motzer, Matthew H Taylor, Thomas R Jeffry Evans, et al.
European Urology|February 25, 2022
Assessing the Safety and Efficacy of Two Starting Doses of Lenvatinib Plus Everolimus in Patients with Renal Cell Carcinoma: A Randomized Phase 2 TrialSumanta K Pal, Javier Puente, Daniel Y C Heng, et al.
European Urology|March 12, 2016
Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate CancerPasquale Rescigno, David Lorente, Diletta Bianchini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2022
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in CombinationAna Arance, Luis de la Cruz-Merino, Teresa M Petrella, et al.
The New England Journal of Medicine|January 19, 2022
Lenvatinib plus Pembrolizumab for Advanced Endometrial CancerVicky Makker, Nicoletta Colombo, Antonio Casado Herráez, et al.
The Lancet. Oncology|June 18, 2021
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 studyChung-Han Lee, Amishi Yogesh Shah, Drew Rasco, et al.
Pageof 5